Contact Us
|
Client Login
PRODUCTS & SERVICES
Antibody Products
Antibody Products Store
Neuroscience
Epitope Tags
Structural Proteins & Cell Components
Signal Transduction
Immunopathology
Detection Chemistries & Ancillaries
Custom Immunology Services
Clinical Services
Bioanalytical
Central Laboratory
Clinical Development (Phase I-III)
Discovery & Translational Services
Antibody Products
Biomarker Center of Excellence
BioPathways
Computational Biology
Genomics Laboratory
Immunology
Lead Optimization
Vaccines & Infectious Disease
Nonclinical Services
Antibody Products
Bioanalytical Services
Drug Metabolism & Pharmacokinetics
Immunology
Lead Optimization
Radiosynthesis
Research Models
Safety Pharmacology
Toxicology
Vaccines & Infectious Disease
Biopharmaceutical CMC Solutions
Biorepository Services
Environmental Sciences
Genomics Laboratory
Integration in Drug Development
Market Access
Nutritional Chemistry & Food Safety
Secure Data Access
Strategic Partnering
CAREERS
Search Jobs
College / University
Featured Jobs
Diversity
Benefits
现在就加入科文斯
STUDY PARTICIPANTS
INVESTORS
Investor Information
Investor Home
Stock Information
Board of Directors
Corporate Governance Guidelines
Analyst Coverage
Investor FAQ
Presentations & Webcasts
Financial Information
SEC Filings
Annual Reports
Press Releases
Calendar of Events
Request Information
NEWS
Press Releases
Media Relations
ABOUT COVANCE
Company Overview
Industry Overview
History of Covance
Mission & Vision
Global Locations
Executive Leadership
Events
Corporate Responsibility
Supplier Code of Conduct
Business Integrity Program
Animal Welfare
Covance.Asia
RESOURCE CENTER
Blog
Antibody Products
Bioanalytical
Discovery
Drug Metabolism and Pharmacokinetics
Immunology
Chemistry, Manufacturing and Controls Pharmaceutical Development
Radiosynthesis
Research Models
Safety Pharmacology
Toxicology
Home
> Products & Services >
Nonclinical Services
>
Chemistry, Manufacturing & Controls Pharmaceutical Development Services
>
Facility Inspection History
Chemistry, Manufacturing & Controls Pharmaceutical Development Services
Facility Inspection History
FDA Audit Date
Findings
June 2009 - Harrogate
Facility cGMP Inspection
No Form 483 Issued
March 2009 - Madison
Facility cGMP Inspection
No Form 483 Issued
March 2007
Facility cGMP Inspection
No Form 483 Issued
February 2006
Facility cGMP Inspection
No Form 483 Issued
November 2004
Facility cGMP Inspection
No Form 483 Issued
Home
|
Animal Welfare
|
Privacy Policy
|
Contact Us
|
Site Map
|
Investigators
|
Covance.Asia
RSS
© Copyright 2013 Covance Inc. All rights reserved.